Fundz

Seaport Therapeutics reported raising $226 Million in an initial SEC Form D filing, from an offering of $226 Million

PUBLIC · SPTXOct 31, 2024$225.9M of $226M raised

Amount Raised

$226 Million

$226 Million sold, per SEC Form D (first sale Oct 18, 2024)

Round Type

Venture

BostonBiotechnologyTherapeuticsPharmaceuticalBiopharma

Investors

General Atlantic

Quick answer

Seaport Therapeutics raised $226 Million in a funding round, dated October 18, 2024. Investors: General Atlantic. Seaport Therapeutics is based in Boston, Massachusetts, United States.

How much did Seaport Therapeutics raise?
Seaport Therapeutics raised $226 Million in a funding round on October 18, 2024.
Who invested in Seaport Therapeutics?
General Atlantic is named as investors in this round.
What does Seaport Therapeutics do?
Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs.
Where is Seaport Therapeutics based and how big is it?
Seaport Therapeutics is based in Boston, Massachusetts, United States.
Who are the decision-makers at Seaport Therapeutics?
Fundz holds 1 contact at Seaport Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Seaport Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Bio Green Med Solution, Inc. raised $2.1M (Seed) on November 14, 2024.
  • Ensho Therapeutics raised $5M on October 24, 2024.
  • SystImmune raised $7.9M on October 18, 2024.
  • OnKure Therapeutics raised $65M on October 4, 2024.
  • Clene Nanomedicine raised $7.3M on October 1, 2024.
  • PhoreMost raised $12M (Series B) on September 10, 2024.

Who to call at Seaport Therapeutics, and when

A new round usually means Seaport Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Seaport Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Seaport Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Seaport Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Seaport Therapeutics

Location

Boston, Massachusetts, United States

About

Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs. We have a proven strategy of advancing clinically validated mechanisms previously held back by limitations we overcome with our proprietary Glyph technology platform. All the therapeutic candidates in our pipeline of first and best-in-class medicines are based on the Glyph platform, which is uniquely designed to enable oral bioavailability, bypass first-pass metabolism and reduce hepatotoxicity and other side effects. We are led by an experienced team that was involved in inventing and developing KarXT and other neuropsychiatric medicines, and are guided by an extensive network of renowned scientists, clinicians and key opinion leaders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Seaport Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Seaport Therapeutics's next move

See what Strategic adds

Seaport Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.